Perfil del autor: Gutiérrez Gutiérrez, Belén
Datos institucionales
| Nombre | Gutiérrez Gutiérrez, Belén |
| Departamento | Medicina |
| Área de conocimiento | Medicina |
| Categoría profesional | Profesora Contratada Doctora (Plaza Vinc.) |
| Correo electrónico | Solicitar |
 |
|
Estadísticas
-
Nº publicaciones
20
-
Nº visitas
1527
-
Nº descargas
1897
| Publicaciones |
|---|
Tesis Doctoral
 Factores de riesgo para el desarrollo de infecciones por enterobacterales productores de carbapenemasas
(2024)
INTRODUCCIÓN La resistencia a los antibióticos entre las bacterias ha sido reconocida como uno de los problemas de salud ... |
Tesis Doctoral
Características, manejo clínico y pronóstico de las infecciones por Enterobacterales productores de carbapenemasas
(2023)
Antecedentes. La resistencia a los carbapenémicos (considerados como antibióticos de “último recurso”) hace cada vez más ... |
Artículo
Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control-control study (EURECA)
(2023)
Background Data on risk factors for carbapenem-resistant Enterobacterales (CRE) with wider applicability are needed to ... |
Artículo
Conventional hospitalization versus sequential outpatient parenteral antibiotic therapy for Staphylococcus aureus bacteremia: post-hoc analysis of a multicenter observational cohort
(MDPI, 2023)
It is not known whether sequential outpatient parenteral antimicrobial (OPAT) is as safe and effective as conventional ... |
Artículo
 Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization
(Frontiers Media S.A., 2023)
SARS-CoV-2 infection is the cause of the disease named COVID-19, a major public health challenge worldwide. Differences ... |
Artículo
Association between Timing of Colonization and Risk of Developing Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae Infection in Hospitalized Patients
(AMER SOC MICROBIOLOGY, 2022)
Colonization by KPC-producing Klebsiella pneumoniae (KPC-Kp) is associ ated with the risk of developing KPC-Kp infection. ... |
Artículo
Clinical outcomes of an innovative cefazolin delivery program for MSSA infections in OPAT
(MDPI, 2022)
Cefazolin is a recommended treatment for methicillin-susceptible Staphylococcus aureus (MSSA) infections that has been ... |
Artículo
Association between rectal colonisation by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae and mortality: a prospective, observational study
(Elsevier, 2022)
Objectives We evaluated the association of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae (KPC-Kp) rectal ... |
Artículo
Early Use of Sarilumab in Patients Hospitalized with COVID-19 Pneumonia and Features of Systemic Inflammation: the SARICOR Randomized Clinical Trial
(AMER SOC MICROBIOLOGY, 2022)
The objective of this study was to investigate the efficacy and safety of early treatment with sarilumab, added to standard ... |
Artículo
Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study
(Science Direct, 2021)
Background: We aimed to describe the epidemiology, risk factors, and clinical outcomes of co-infections and superinfections ... |
Artículo
CON: carbapenems are NOT necessary for all infections caused by ceftriaxone-resistant enterobacterales
(2021)
Carbapenems are considered the drugs of choice for the treatment of serious infections caused by ceftriaxone resistant ... |
Artículo
Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients
(Willey-Blackwell, 2021)
Background Whether active therapy with β-lactam/β-lactamase inhibitors (BLBLI) is as affective as carbapenems for ... |
Artículo
Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients
(American Society Microbiology, 2021)
There are scarce data on the efficacy of ertapenem in the treatment of bacteremia due to extended-spectrum-beta-lactamase ... |
Artículo
Identification and validation of clinical phenotypes with prognostic implications in patients admitted to hospital with COVID-19: a multicentre cohort study
(Elsevier, 2021)
Background The clinical presentation of COVID-19 in patients admitted to hospital is heterogeneous. We aimed to determine ... |
Artículo
Temocillin versus meropenem for the targeted treatment of bacteraemia due to third-generation cephalosporin-resistant Enterobacterales (ASTARTÉ): protocol for a randomised, pragmatic trial
(BMJ Publishing Group, 2021)
Introduction: Alternatives to carbapenems are needed in the treatment of third-generation cephalosporin-resistant ... |
Artículo
Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection
(MDPI, 2020)
Bezlotoxumab is marketed for the prevention of recurrent Clostridioides difficile infection (rCDI). Its high cost could ... |
Artículo
Predictors of mortality in solid organ transplant recipients with bloodstream infections due to carbapenemase-producing Enterobacterales: the impact of cytomegalovirus disease and lymphopenia
(BMC, 2020)
Treatment of carbapenemase-producing Enterobacterales bloodstream infections in solid organ transplant recipients is ... |
Artículo
Intestinal colonization due to Escherichia coli ST131: Risk factors and prevalence
(Biomed Central, 2018)
Background Escherichia coli sequence type 131 (ST131) is a successful clonal group that has dramatically spread during the ... |
Artículo
EUropean prospective cohort study on Enterobacteriaceae showing REsistance to CArbapenems (EURECA): a protocol of a European multicentre observational study
(2017)
Introduction: The rapid worldwide spread of carbapenem-resistant Enterobacteriaceae (CRE) constitutes a major challenge. ... |
Tesis Doctoral
Tratamiento de bacteriemias por enterobacterias productoras de β-lactamasas de espectro extendido la combinación de β-lactámicosinhibidores de β-lactamasas como alternativa a los carbapenemes. Proyecto INCREMENT
(2015)
En los últimos años, la diseminación de las enterobacterias productoras de β-lactamasas de espectro extendido (E-BLEE) se ... |